专题：Lung Cancer Research Studies

This cluster of papers represents a comprehensive exploration of small cell lung cancer, covering topics such as genomic profiles, immunotherapy, chemotherapy, prognostic factors, biomarkers, targeted therapy, clinical trials, metastasis, and tumor markers.
最新文献
Efficacy and safety of immune checkpoint inhibitor rechallenge following immune-related adverse events: a review

review Full Text OpenAlex

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer

article Full Text OpenAlex

Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study

article Full Text OpenAlex

Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages

article Full Text OpenAlex

Cerebrospinal Fluid Metabolomics and Machine Learning Identify Novel Biomarkers for Lung Cancer Leptomeningeal Metastasis

article Full Text OpenAlex

Comparison of efficacy and safety of first-line immunotherapy combined with chemotherapy in extensive-stage small cell lung cancer, a retrospective study

article Full Text OpenAlex

PROTAC-mediated structure–function disruption of CD26: a therapeutic strategy for driver-negative non-small cell lung cancer

article Full Text OpenAlex

Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial

article Full Text OpenAlex

Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1/DAXX/ATRX Explain Biological Variability

article Full Text OpenAlex

The impact of brain metastases on outcome in metastatic breast cancer and extensive-stage small cell lung cancer

article Full Text OpenAlex

近5年高被引文献
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1379 FWCI201.2155

Lung cancer immunotherapy: progress, pitfalls, and promises

review Full Text OpenAlex 964 FWCI224.2586

Immune checkpoint therapy—current perspectives and future directions

review Full Text OpenAlex 925 FWCI217.4871

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

article Full Text OpenAlex 919 FWCI242.6127

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

review Full Text OpenAlex 882 FWCI130.0556

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

review Full Text OpenAlex 844 FWCI162.5687

First-Line Immunotherapy for Non–Small-Cell Lung Cancer

article Full Text OpenAlex 811 FWCI83.0921

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

review Full Text OpenAlex 727 FWCI105.7845

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 709 FWCI185.697

Non‐small cell lung cancer in China

review Full Text OpenAlex 612 FWCI86.6339